LMO1 and acute leukemia: In the murine SCL-LMO1 transgenic model, progression to acute leukemia is driven by the acquisition of Notch1 gain-of-function mutations, starting at 7–8 weeks of age (Fig. 2a; Supplementary Fig. 2a), reproducing a major feature of the human disease.